Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and Challenges
about
Exosomes, an Unmasked Culprit in Neurodegenerative Diseases.Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome.ATP Binding Cassette Subfamily A Member 2 (ABCA2) Expression and Methylation are Associated with Alzheimer's Disease.c-Abl and Parkinson's Disease: Mechanisms and Therapeutic Potential.
P2860
Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and Challenges
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Harnessing Cerebrospinal Fluid ...... ases: Potential and Challenges
@ast
Harnessing Cerebrospinal Fluid ...... ases: Potential and Challenges
@en
Harnessing Cerebrospinal Fluid ...... ases: Potential and Challenges
@nl
type
label
Harnessing Cerebrospinal Fluid ...... ases: Potential and Challenges
@ast
Harnessing Cerebrospinal Fluid ...... ases: Potential and Challenges
@en
Harnessing Cerebrospinal Fluid ...... ases: Potential and Challenges
@nl
prefLabel
Harnessing Cerebrospinal Fluid ...... ases: Potential and Challenges
@ast
Harnessing Cerebrospinal Fluid ...... ases: Potential and Challenges
@en
Harnessing Cerebrospinal Fluid ...... ases: Potential and Challenges
@nl
P2093
P2860
P921
P3181
P1476
Harnessing Cerebrospinal Fluid ...... ases: Potential and Challenges
@en
P2093
Chang-Shin Park
Dong Wun Shin
Ju-Hee Kang
Young-Sam Kim
P2860
P304
P3181
P356
10.3988/JCN.2016.12.4.381
P407
P577
2016-10-01T00:00:00Z